- Raised funding round
About
IDD Therapeutics Ltd develops drugs for cancer therapy. The company's main focus is improving the safety and efficacy of existing cancer treatments and protocols. The company's proprietary Intelligent Learning Engine (ILE) helps researchers design targeted small-molecule New Therapeutic Entities (NTEs) for cancer therapy. IDD is developing atargeted, multifunctional Mode of Action (MoA) NTE consisting of a neuro-protective antioxidant moiety. IDD-1040 is a small molecule synthesized in a one-step chemical procedure that has the potential to be safer and more effective than many existing treatments. Additional drug candidates, IDD-1010 and IDD-2010, are currently at the early preclinical stage. IDD Therapeutics operates within the New Generation Technology (NGT) incubator, funded by the Israeli Office of the Chief Scientist and private capital.
Funding history · 1 round · — total
Q&A
- What is IDD Therapeutics' primary focus?
- IDD Therapeutics Ltd develops drugs for cancer therapy, with a main focus on improving the safety and efficacy of existing cancer treatments and protocols.
- What technology does IDD Therapeutics utilize in its drug discovery process?
- IDD Therapeutics uses a proprietary Intelligent Learning Engine (ILE) to help researchers design targeted small-molecule New Therapeutic Entities (NTEs) for cancer therapy.
- What are some of IDD Therapeutics' drug candidates?
- IDD Therapeutics is developing IDD-1040, a targeted, multifunctional Mode of Action (MoA) NTE. Additional drug candidates, IDD-1010 and IDD-2010, are currently at the early preclinical stage.
- When was IDD Therapeutics founded?
- IDD Therapeutics was founded in January 2010.
- What is the current status of IDD Therapeutics?
- IDD Therapeutics is currently inactive, as of January 2014.
- Where is IDD Therapeutics headquartered?
- IDD Therapeutics is headquartered in Nazareth, North District, Israel.
- How many employees does IDD Therapeutics have?
- IDD Therapeutics has 1-10 employees.
- Which investor participated in IDD Therapeutics' funding round?
- The Office of the Chief Scientist participated in IDD Therapeutics' funding round.
Team · 1
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2010-1 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Jan 2014 |